Gabriel Cuonzo is a co-founder of Trevisan & Cuonzo and he is considered by his clients as "the go-to lawyer for challenging cases in Italy". He has a superb reputation for cutting edge multi-jurisdictional IP litigation.
With over 30 years courtroom experience, Gabriel has represented many multinational companies before the Italian courts in a broad range of high profile cases with an international dimension: over the years these have included big name clients and landmark cases such as Scott Paper Company v. Kaysersberg (1994), Fujitsu v. Samsung (1997), Rambus v. Micron (2000), TRW v. Koyo (2006), Pronova v. Chiesi (2006), Ciba Vision v. Johnson & Johnson (2007), Angiotech v. Conor (2007), Novartis v. Actavis (2008), Unilever v. Nestlè (2008), Novartis v. Teva (2009), Astrazeneca v. Teva (2011), Biotec v. Novamont (2012). Bogner v. Bencom (2012), Harley-Davidson v. Pirelli (2013), Novartis v. Doc Generici (2014), Boehringer Ingelheim v. Actavis (2014), Seattle Genetics – Takeda v. Arizona State University (2015), Beiersdorf v. Neve Cosmetics (2015), Unilever v. Colgate (2015), Briggs v. Honda (2016), Boehringer Ingelheim v. Teva (2018).
With an excellent understanding of international law and as a skilled linguist, Gabriel takes a pragmatic, solution oriented approach to commercial matters and is often involved in complex, mostly IP driven, international transactions. Gabriel is widely regarded as a leading figure in pharmaceutical litigation and regulatory work.
Education/Alumni:
- Max-Planck Institute, Munich (1987)
- University of Bari (J.D. 1982)
Network Memberships: AIPPI, IBA, GRUR and INTA
Last updated 7th June 2020
.png)
